Results 51 to 60 of about 34,092 (295)
, 2017 Von Willebrand Disease (VWD) is a blood clotting disorder characterized by low levels of the Von Willebrand Factor (VWF) in the blood. VWF is functions to bind platelets and promote clotting of the blood when vascular injury occurs.
Misla David, Ramon
core +2 more sources
Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial [PDF]
Avicenna Journal of Phytomedicine, 2020 Objective: Golnar product is a poly herbal formulation advised by Persian medicine to control heavy menstrual bleeding (HMB). This study was conducted to compare the efficacy of this product with placebo in patients with HMB.
Fataneh Hashem-Dabaghian +6 more
doaj +1 more source
Journal of Ultrasound in Medicine, EarlyView.Objectives High‐intensity focused ultrasound (HIFU) has demonstrated efficacy as a non‐invasive treatment for uterine fibroids, though individual variability exists. This study aims to develop a risk scoring model using clinical and biochemical features to predict HIFU treatment outcomes.
Huiqing Li +6 more
wiley +1 more source
Journal of Gandhara Medical and Dental Sciences, 2015 OBJECTIVES: To determine the causes of menorrhagia MATERIAL AND METHODS: This case series study was conducted in the department of obstetrics and Gyneacology Naseer Teaching Hospital Peshawar over a period of one year from June 2006 to May 2007.
Anjum Ara, Naheed Rahim
doaj +1 more source
Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. [PDF]
, 2020 BackgroundThe levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleeding treatment in clinical trials, but few data exist to demonstrate how rapidly the effects occur and the effects in women with self-reported heavy ...
Chen, Beatrice A +5 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Direct oral anticoagulants (DOACs) have quickly gained favor due to oral availability, favorable risk profile, and reduced lab monitoring. This study aims to evaluate trends in DOAC use among pediatric patients with new venous thrombotic events (VTE) and factors associated with their selection.
Molly Mack +2 more
wiley +1 more source
Sensitivity to scale of willingness-to-pay within the context of menorrhagia [PDF]
, 2016 Objectives: Willingness-to-pay (WTP) provides a broad assessment of well-being, capturing benefits beyond health. However, the validity of the approach has been questioned and the evidence relating to the sensitivity of WTP to changes in health status is
Bannigan +31 more
core +3 more sources
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 7, Page 961-971, June 2025.ABSTRACT Objective To assess the association between menstrual disorders and workforce participation among Australian women. Design Population‐based cohort study. Setting Secondary analysis of eight surveys collected between 2000 and 2021. Population A total of 11 152 Australian women, born between 1973 and 1978.
Biresaw Wassihun Alemu +2 more
wiley +1 more source
Can We Predict Menorrhagia with Intrauterine Contraceptive Device (IUCD) Insertion
, 2017 Objective: Studying sub endometrial vascularity and blood flow in cases using intrauterine contraceptive devices for contraception with and without menorrhagia compared to cases not using intrauterine contraceptive devices.
G. Mansour +5 more
semanticscholar +1 more source
Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia [PDF]
, 2017 The most worrying complication of replacement therapy for severe hemophilia A and B is currently the occurrence of inhibitory alloantibodies against infused factor VIII and factor IX, respectively.
Franchini, Massimo +6 more
core +1 more source